(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563836

女性の健康診断の世界市場

Women's Health Diagnostics

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円
女性の健康診断の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

女性の健康診断の世界市場は2030年までに439億米ドルに達する

2023年に297億米ドルと推定される女性の健康診断の世界市場は、分析期間2023-2030年にCAGR 5.7%で成長し、2030年には439億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである乳がん検査アプリケーションは、CAGR 7.3%を記録し、分析期間終了時には113億米ドルに達すると予測されます。感染症検査アプリケーション分野の成長率は、分析期間中CAGR 4.7%と推定されます。

米国市場は79億米ドルと推定、中国はCAGR 9.9%で成長予測

米国の女性の健康診断市場は2023年に79億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに106億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは9.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と5.8%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の女性健康診断市場- 主要動向と促進要因のまとめ

なぜ女性の健康診断がヘルスケアで脚光を浴びているのか？

乳がん、子宮頸がん、骨粗しょう症、生殖器疾患など、主に女性が罹患する疾患の早期発見、予防、管理に対する意識の高まりと注目により、ヘルスケアにおいて女性用健康診断が脚光を浴びています。これらの診断薬には、画像診断、分子診断、ポイントオブケア検査、ラボベースのアッセイなど、さまざまなライフステージにわたる女性の健康をモニター・管理するための幅広い検査やスクリーニング法が含まれます。個別化医療、予防医療、患者中心のアプローチがますます重視される中、女性の健康診断は、世界中の女性の健康転帰と生活の質を向上させるために不可欠なものとなりつつあります。

どのような技術革新が女性の健康診断に変革をもたらすのか？

分子診断、画像診断、ポイントオブケア検査における技術の進歩は、女性の健康診断に大きな変化をもたらしています。次世代シークエンシング（NGS）、リキッドバイオプシー、コンパニオン診断の開発により、遺伝子変異、がん、その他の健康状態をより正確かつ非侵襲的に検出することが可能になり、より的を絞った治療や個別化された治療計画につながっています。3Dマンモグラフィ、超音波、磁気共鳴画像法（MRI）などの画像技術の革新は、乳房組織をより正確かつ詳細に可視化し、乳がんの早期発見・診断を強化しています。さらに、AI主導の分析、デジタル病理学、遠隔医療の統合は、女性の健康診断のアクセシビリティ、効率性、正確性を向上させ、より患者にやさしく、費用対効果の高いものにしています。

女性の健康診断市場における課題と機会とは？

女性の健康診断市場は、高度な診断検査の高額な費用、低所得地域における質の高いヘルスケアへの限られたアクセス、女性の健康問題に対する認識と教育の向上の必要性など、いくつかの課題に直面しています。また、診断検査の規制状況や償還状況も複雑で時間がかかります。しかし、こうした課題は成長とイノベーションの大きな機会となっています。がん、心血管疾患、骨粗鬆症などの慢性疾患の有病率の増加が、早期発見と予防診断の需要を促進しています。個別化医療、遠隔医療、在宅検査の台頭は、革新的で利用しやすく手頃な価格のソリューションを提供する診断薬メーカーに新たな成長機会をもたらしています。さらに、女性の健康擁護、政府イニシアティブ、公衆衛生キャンペーンへの関心の高まりが、包括的かつ統合的な女性の健康診断の必要性を高めています。

何が女性の健康診断市場の成長を促進しているのか？

女性の健康診断市場の成長は、女性の慢性疾患や生活習慣病の有病率の増加、早期発見や個別化医療に対する需要の高まり、分子診断、画像診断、AI主導の分析における技術進歩など、いくつかの要因によってもたらされます。早期発見、非侵襲的検査、標的治療を提供する包括的で正確な診断ソリューションに対するニーズは、ヘルスケアプロバイダーと患者が女性の健康転帰とQOLの向上を求める中で、市場の需要を大幅に押し上げています。次世代シーケンシング、デジタル病理学、AI主導型診断、遠隔医療などの技術革新は、女性の健康診断の能力とアクセシビリティを高め、ヘルスケア専門家と患者の双方にとってより魅力的なものとなっています。予防医療の拡大、遠隔医療と在宅検査の成長、女性の健康擁護と意識向上への注目の高まりも、利害関係者が女性の健康のための高度で統合的な診断ソリューションを求めていることから、市場の成長を後押ししています。

調査対象企業の例（注目の41社）

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15688

Global Women's Health Diagnostics Market to Reach US$43.9 Billion by 2030

The global market for Women's Health Diagnostics estimated at US$29.7 Billion in the year 2023, is expected to reach US$43.9 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Breast Cancer Testing Application, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Infectious Disease Testing Application segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.9 Billion While China is Forecast to Grow at 9.9% CAGR

The Women's Health Diagnostics market in the U.S. is estimated at US$7.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.6 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Women’s Health Diagnostics Market - Key Trends & Drivers Summarized

Why Is Women’s Health Diagnostics Gaining Prominence in Healthcare?

Women’s health diagnostics is gaining prominence in healthcare due to the growing awareness and focus on early detection, prevention, and management of diseases that predominantly affect women, such as breast cancer, cervical cancer, osteoporosis, and reproductive health disorders. These diagnostics encompass a wide range of tests and screening methods, including imaging, molecular diagnostics, point-of-care testing, and lab-based assays, to monitor and manage women's health across different life stages. With the increasing emphasis on personalized medicine, preventive care, and patient-centric approaches, women’s health diagnostics are becoming essential for improving health outcomes and quality of life for women worldwide.

What Technological Innovations Are Transforming Women’s Health Diagnostics?

Technological advancements in molecular diagnostics, imaging, and point-of-care testing are significantly transforming women’s health diagnostics. The development of next-generation sequencing (NGS), liquid biopsy, and companion diagnostics is enabling more precise and non-invasive detection of genetic mutations, cancers, and other health conditions, leading to better-targeted therapies and personalized treatment plans. Innovations in imaging technologies, such as 3D mammography, ultrasound, and magnetic resonance imaging (MRI), are providing more accurate and detailed visualization of breast tissues, enhancing early detection and diagnosis of breast cancer. Additionally, the integration of AI-driven analytics, digital pathology, and telemedicine is improving the accessibility, efficiency, and accuracy of women’s health diagnostics, making them more patient-friendly and cost-effective.

What Are the Challenges and Opportunities in the Women’s Health Diagnostics Market?

The women’s health diagnostics market faces several challenges, including the high cost of advanced diagnostic tests, limited access to quality healthcare in low-income regions, and the need for increased awareness and education about women’s health issues. The regulatory and reimbursement landscape for diagnostic tests can also be complex and time-consuming. However, these challenges present significant opportunities for growth and innovation. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and osteoporosis, is driving the demand for early detection and preventive diagnostics. The rise of personalized medicine, telehealth, and home-based testing is creating new growth opportunities for diagnostic manufacturers to offer innovative, accessible, and affordable solutions. Moreover, the growing focus on women’s health advocacy, government initiatives, and public health campaigns is driving the need for comprehensive and integrated women’s health diagnostics.

What Is Driving the Growth of the Women’s Health Diagnostics Market?

The growth in the Women’s Health Diagnostics market is driven by several factors, including the increasing prevalence of chronic and lifestyle-related diseases among women, rising demand for early detection and personalized medicine, and technological advancements in molecular diagnostics, imaging, and AI-driven analytics. The need for comprehensive and accurate diagnostic solutions that offer early detection, non-invasive testing, and targeted therapies is significantly boosting market demand as healthcare providers and patients seek to improve health outcomes and quality of life for women. Technological innovations such as next-generation sequencing, digital pathology, AI-driven diagnostics, and telemedicine are enhancing the capabilities and accessibility of women’s health diagnostics, making them more attractive to both healthcare professionals and patients. The expansion of preventive care, the growth of telehealth and home-based testing, and the increasing focus on women’s health advocacy and awareness are also driving market growth as stakeholders seek advanced and integrated diagnostic solutions for women’s health.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Quest Diagnostics, Inc.
  • Siemens AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Women's Health Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Growing Awareness for Early Detection in Women
    • Increasing Demand for Point-of-Care and Home-Based Diagnostic Solutions
    • Advancements in Molecular Diagnostics and Next-Generation Sequencing for Women's Health
    • Growing Focus on Personalized Medicine and Companion Diagnostics for Targeted Therapies
    • Impact of Digital Health and Telemedicine on Women's Health Diagnostics Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Women's Health Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Breast Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cervical Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Osteoporosis Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prenatal Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Prenatal Genetic Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pregnancy & Fertility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pregnancy & Fertility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Diagnostic & Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • CHINA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • INDIA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Infectious Disease Testing, Cervical Cancer Testing, Osteoporosis Testing, Prenatal Genetic Screening, Pregnancy & Fertility Testing and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2014, 2024 & 2030

IV. COMPETITION